Vitamin K-dependent actions of Gas6 by Bellido-Martín, Lola & García de Frutos, Pablo
  
 
 
 
Vitamin K dependent actions of Gas6. 
 
Lola Bellido-Martín, Pablo García de Frutos 
 
Department of Cell Death and Proliferation, Institute for Biomedical Research of Barcelona, 
IIBB-CSIC-IDIBAPS, Barcelona, Spain. 
 
 
 
Correspondence to: Pablo García de Frutos, Institute for Biomedical Research of Barcelona 
(IIBB-CSIC-IDIBAPS), Roselló 161 p6, 08036 Barcelona, Spain  
Tel: +34 933632382 
Fax: +34 933638301  
Email: pgffat@iibb.csic.es 
 
 
 
Abstract 
GAS6 (growth arrest-specific gene 6) is the last addition to the family of plasma vitamin K-
dependent proteins. Gas6 was cloned and characterized in 1993 and found to be similar to the 
plasma anticoagulant protein S. Soon after it was recognized as a growth factor-like 
molecule, as it interacted with receptor tyrosine kinases of the TAM family; Tyro3, Axl and 
MerTK. Since then, the role of Gas6, protein S and the TAM receptors has been found to be 
important in inflammation, hemostasis and cancer, making this system an interesting target in 
biomedicine. Gas6 employs a unique mechanism of action, interacting through its vitamin K-
dependent Gla module with phosphatidylserine-containing membranes and through its 
carboxy-terminal LG domains with the TAM membrane receptors. The fact that these 
proteins are affected by anti-vitamin K therapy is discussed in detail. 
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I. Introduction 
The family of plasma vitamin K-dependent proteins was well established after the 
discovery of carboxylation in 1974 (Stenflo 2006). Plasma vitamin K-dependent proteins 
included the coagulation factors VII, IX, X and prothrombin and the natural anticoagulants 
protein C, protein S and protein Z, all of them characterized by a preserved N-terminal Gla 
domain, which contained the carboxyglutamic residues of the protein of hemostasis. 
Therefore, it was a surprise when in a screening for genes which expression was up regulated 
under conditions of growth arrest in embryonic mouse NIH 3T3 fibroblasts, the group of Dr. 
Schneider found a gene with a sequence related to the anticoagulant protein S (Schneider et 
al. 1988; Manfioletti et al. 1993). The gene was named growth arrest-specific gene 6, (Gas6; 
MIM#14456) and its expression was found to be increased around 30 times when the cell 
entered the G0 phase of the cell cycle. Shortly afterwards, the same group and others cloned 
the cDNA derived from the ortholog gene of human PROS1 (MIM#176880) in the mouse 
(Pros1; MIM#19128) and the ortholog of Gas6 in humans (GAS6; MIM#600441), 
demonstrating that they were two distinct entities, despite more than a 40% identity among 
protein S and Gas6 protein sequences. Therefore, the short list of proteins dependent on 
vitamin K in plasma had a new genuine member.  
 
II. Gas6 structure 
Gas6 is a multimodular protein containing several post-transcriptional modifications 
(Fig. 1). The main subject of this review is the -carboxylation of the N-terminal domain, the 
Gla module (Hansson & Stenflo 2005). Gla modules of plasma -carboxylated factors have a 
common fold, which is preserved in Gas6. Together with protein S and prothrombin, Gas6 
contains a disulfide-bridged thumb loop, although it does not seem to be cleaved by the 
action of serine proteases, as it is the case of protein S, which is inactivated by thrombin or 
factor Xa specific cleavages in this region. From this connecting sequence, four epidermal 
growth factor-like modules are arranged in tandem, two of them with calcium-binding 
consensus sequences. The C terminal region contains two domains similar to the globular 
folds of the laminin A chain (LG domains), a structure that is also found in the sex-hormone 
binding globulin (Villoutreix et al. 1997; Sasaki et al. 2002). The sequence similarity between 
protein S and Gas6 is probably reflected in a close general structure, as suggested by 
modeling experiments using the available structures of Gas6 or protein S fragments 
(Dahlbäck & Villoutreix 2005).  
Despite this similitude, Gas6 and protein S seem to differ in function, as it is reflected 
by the tissue expression of GAS6 and PROS1. Most plasma vitamin K-dependent factors have 
a gene expression restricted to liver, especially in the case of factor IX and factor X (Fig. 2). 
The expression of PROS1 is not so specific of liver, and comparable levels of transcript can 
be found in kidney, lungs or gonads. GAS6 is unique among the genes of the family, because 
GAS6 expression in liver is minor compared with other tissues, including heart, kidney and 
lung (Fig. 2). The presence of Gas6 in plasma has been carefully evaluated. Although its 
presence can be detected, the concentration is quite small, around 20-50ng/mL, or 0.25 nM 
(Balogh et al. 2005; Borgel et al. 2006); or even lower according to other reports (Gibot et al. 
2007). In any case, the concentration of Gas6 is much lower that the rest of the vitamin K-
dependent proteins of plasma, which range from 10 nM for factor VII to 1.5 M for 
prothrombin. The range of Gas6 concentration is also much lower than the for protein S, 
which increases up to 400 nM during an acute-phase response (Garcia et al. 1994). 
 
III. Cellular effects of Gas6 
The function of Gas6 has been debated from its discovery. The fact that it was a cell 
arrest-regulated gene suggested that it could act as a factor involved in cellular homeostasis. 
Indeed, Gas6 was identified as a growth factor and a rescue factor from apoptosis on different 
cell types, specifically in cultured cells deprived from serum (Nakano et al. 1995; Li et al. 
1996; Goruppi et al. 1996). Growth factors are major effectors of cell differentiation, 
duplication and survival. Their effect is mediated by the interaction with specific cell 
membrane receptors, most of them with a tyrosine kinase activity, (receptor tyrosine kinases 
or RTKs). RTKs are a large group of genes with a highly conserved intracellular tyrosine 
kinase domain. Intracellular signaling is triggered upon ligand binding, which induces 
dimerization/oligomerization of the receptor transducing the signal to the intracellular portion 
of the molecule and leading to activation of the tyrosine kinase activity. An essential early 
substrate of tyrosine phosphorylation is the RTK itself. RTKs are classified according to their 
extracellular domain, generally composed of a modular structure (Fig. 1). Members of a 
subgroup of RTKs often bind common or similar ligands. 
A crucial discovery in the understanding of the biology of Gas6 was the discovery that 
it was a ligand of a previously orphan RTK, Axl. Axl was part of a three member family of 
receptors composed of Axl, Tyro3 and MerTK, which had been cloned by different groups 
and given different names: Axl (ARK, Tyro7, Ufo) Tyro3 (Sky, Rse, Brt, Dtk, Tif, Etk2, 
Rek), and MerTK (Mer, c-Eyk, Nyk, Tyro12). The architecture of these receptors is 
preserved, and it is constituted by two immunoglobulin domains followed by two fibronectin 
type III (Fig. 1). This receptor tyrosine kinase family is named TAM from the first letter of 
the three components (Tyro3, Axl and MerTK). 
From the early studies of Gas6 action on cultured cells, the anti-apoptotic effect of 
Gas6 has been found in many experimental settings, as well as in different species. This has 
been observed in almost all cell types and lines tested, including NIH3T3 fibroblasts 
(Goruppi et al. 1996; Bellosta et al. 1997; Goruppi et al. 1999), VSMCs (Nakano et al. 1996; 
Melaragno et al. 2004; Konishi et al. 2004), endothelial cells (O'Donnell et al. 1999; Healy et 
al. 2001; Hasanbasic et al. 2004), chondrocytes (Loeser et al. 1997), neurons (Allen et al. 
1999; Yagami et al. 2003), oligodendrocytes (Shankar et al. 2003), hepatocytic precursors 
(Couchie et al. 2005), epithelial cells (Valverde et al. 2004), and different types of cancer 
cells (van Ginkel et al. 2004; Vajkoczy et al. 2006; Sawabu et al. 2007). The anti-apoptotic 
effect was observed after treatment with different stimuli inducing cell death, including 
serum deprivation, but also more specific effectors as TNF-  (Bellosta et al. 1997; O'Donnell 
et al. 1999; Valverde et al. 2004; Shankar et al. 2006), changes in pH (D'Arcangelo et al. 
2002), oxidative stress (Konishi et al. 2004; Valverde 2005), soluble phospholipase (Yagami 
et al. 2003) or the amyloid peptide (Yagami et al. 2002). The anti-apoptotic effect of Gas6 
requires protein phosphorylation, as general inhibitors as staurosporine abolished it (Bellosta 
et al. 1997), and in most cases, the PI3K pathway has been demonstrated to be crucial for this 
effect (see below). Interestingly, ultraviolet light exposure, which induces apoptosis in a p53 
dependent manner, was not affected by Gas6/Axl  (Bellosta et al. 1997).  
 While the anti-apoptotic effect of Gas6 has been repeatedly documented, it has not 
been so easy to study the mitogenic activity of the molecule. In certain cell types, a mitogenic 
effect has been described as a potentiating effect on other factors. Indeed, Gas6 was cloned as 
a growth potentiating factor for prothrombin on vascular smooth muscle cells (VSMCs) 
(Nakano et al. 1995). Gas6 stimulates also the mitogenic effect of EGF on cardiac fibroblasts 
(Stenhoff et al. 2004), and has been also reported to stimulate heregulin mitogenic activity on 
Schwann cells (Li et al. 1996). The mitogenic effect observed in these experiments did not 
seem to be dependent on PI3K activation, rather it was mediated through activation of the 
Ras/ERK pathway in most cases (Goruppi et al. 1996; Fridell et al. 1996; Goruppi et al. 1997; 
Goruppi et al. 1999; Sainaghi et al. 2005). Nevertheless, significant differences have been 
reported depending on the cell type and context studied (Goruppi et al. 2001), which could 
reflect differences in the span of Gas6 receptors expressed by the cells studied. Indeed, Gas6 
has been shown to induce mesangial cell proliferation in cultured cells in a STAT3 dependent 
manner that correlates with Axl activation (Doi 2001; Yanagita et al. 2001b). It is possible 
that in certain cell types or in undifferentiated cancer cells Gas6/Axl would have a more clear 
mitogenic effect than in other cell types (Sainaghi et al. 2005). 
A further cellular action of Gas6 is the induction of chemotaxis of VSMCs (Fridell et 
al. 1998). An effect on cell migration has been suggested to play a role on gonadotropin 
releasing hormone (GnRH) neurons migration into the hypothalamus during development 
(Allen et al. 2002; Nielsen-Preiss et al. 2007). In certain tumor types, migration and 
invasiveness has been correlated with the expression of Gas6 receptors, in particular Axl 
(Shieh et al. 2005), and Gas6 dependent signaling through Axl has been shown to promotes 
invasiveness of glioma cells in animal models (Vajkoczy et al. 2006). 
Another cellular effect which has been demonstrated for Gas6 is the targeting of 
apoptotic cells and induction of phagocytosis by macrophages and other phagocytic cell types 
(Ishimoto et al. 2000). The induction of phagocytosis has been shown to be specific of 
apoptotic cell removal or phosphatidylserine containing liposomes, mimicking the situation 
in the cellular membranes of apoptotic cells (Ishimoto et al. 2000; Hall et al. 2001; Wu et al. 
2005; Wu et al. 2006), while Gas6 does not influence the phagocytic capacity of these cells 
on bacteria, yeast or particulate substrates (Scott et al. 2001; Wu et al. 2006). The mechanism 
of Gas6 action could be linked to an integrin cooperative recognition of apoptotic cells and 
subsequent activation of macrophages (Wu et al. 2005). Unraveling the mechanisms and 
molecules implicated in the phagocytosis of apoptotic cells and the resolution of 
inflammation has demonstrated that it is a specific process (Wu et al. 2006). The new term 
efferocytosis has been proposed to designate the specific removal of apoptotic cells by 
phagocytic cells (Vandivier et al. 2006). Related to the effect on apoptotic clearance, Gas6 
has been implicated in the formation of cellular aggregates mediated by Axl. Initially, it was 
shown that the mouse Axl receptor was able to induce cellular aggregation in the absence of 
substrates when expressed as a transgene in Drosophila cells (Bellosta et al. 1995). 
Afterwards, the formation of aggregates was found to be dependent on the presence of Gas6 
in mammalian cells (McCloskey et al. 1997). Nevertheless, recent studies have shown that 
the soluble form of Axl is able to induce signaling through membrane-bound Axl when 
coated on plates, indicating that a possible homophilic interaction among Axl molecules 
independent of ligands is potentially relevant (Budagian et al. 2005a). 
Some studies have found a regulatory role of Gas6 on cell activation and 
differentiation. Cells from innate immunity down regulated the expression of inflammatory 
cytokines after Gas6 stimulation, a function that has been mainly attributed to the interaction 
with MerTK (Camenisch et al. 1999; Correll et al. 2004; Sharif et al. 2006; Li et al. 2006). In 
contrast, MerTK activation seems to mediate IL-8 induction in prostate cancer cells (Wu 
2004), inducing its differentiation. Induction of differentiation by Gas6 has also been reported 
in the maturation process of natural killer cells (Walzer & Vivier 2006; Caraux et al. 2006) 
and adipocytes (Shugart et al. 1995; Maquoi et al. 2005). Gas6 has shown an activity as 
modulator of differentiation models on cells of the vessel wall, including the inhibition of 
osteogenic differentiation of pericytes (Collett et al. 2003) and the differentiation of VSMCs 
into foam cells, as shown by the induction of the expression of specific markers as the 
scavanger receptor A (Murao et al. 1999; Ming et al. 2001). This properties could have an 
important role in the cellular homeostasis of the vasculature after damage (Melaragno et al. 
1999). 
 
IV. Interaction with TAM receptor molecules and signal transduction in the Gas6/TAM 
ligand/receptor system. 
The first report proposing Gas6 as a ligand for TAM receptors showed that Gas6 
engagement induced auto-phosphorylation of the Axl receptor (Varnum et al. 1995). The 
active receptor recruits components of several signaling pathways. One of the first molecules 
to be reported as recruited after Gas6 stimulation of the Axl RTK were PI3K subunits 
(Goruppi et al. 1997). Furthermore, docking sites in Axl intracellular kinase domain for PI3K 
subunits, Grb2, c-Src and Lck were localized in phosphorylated tyrosines Y821, Y779 and 
Y866 (Braunger et al. 1997). Other partners of Axl have been proposed using the yeast two-
hybrid system, including SOCS-1, Nck2 and C1-TEN, proteins containing Src homology 2 
domains (SH2), apart from confirming the previously found interactions with PI3K 
components and Grb2 (Hafizi et al. 2002). 
To date, almost all studies have found a link between PI3K activation and Gas6/Axl 
effect on cells. The activation of the PI3K pathway has been shown to be indispensable for 
the anti-apoptotic effect of Gas6 on different cell types (Goruppi et al. 1999; Allen et al. 
1999; Lee et al. 2002; Hasanbasic et al. 2004). The cell survival effect is blocked by 
pharmacological inhibitors of the PI3K pathway (Goruppi et al. 1997; Goruppi et al. 1999; 
Allen et al. 1999; Melaragno et al. 2004; Hasanbasic et al. 2004). Axl mutants which are not 
capable of interacting with PI3K subunits block also the survival effect of Gas6 on cells 
(Melaragno et al. 2004; Vajkoczy et al. 2006). Several isoforms of PI3K have been shown to 
interact with Axl, and they could potentially lead to discrete signaling pathways from the 
receptor (Braunger et al. 1997; Hafizi et al. 2002), and this could have different implications 
depending on the cell type studied. The activation of PI3K initiates the activation of the anti-
apoptotic Akt/PKB pathway, which inhibition downstream of PI3K also blocks the anti-
apoptotic effect of Gas6. In this context it is interesting that C1-TEN, a protein phosphatase 
similar to the PI3K/Akt/PKB inhibitor PTEN was also found to interact with Axl, although 
the potential regulatory role of the Axl/C1-TEN interaction has not been elucidated (Hafizi et 
al. 2002). Downstream substrates of Akt/PKB shown to be modulated by Gas6 include the 
anti-apoptotic phosphorylation of Bad (Goruppi et al. 1999; Lee et al. 2002). Further, the 
PI3K/Akt/PKB pathway activates NF B transcriptional activity, increasing the concentration 
of Bcl-2, among other effects (Demarchi et al. 2001; Hasanbasic et al. 2004). Another 
effector of the Akt/PKB pathway in the context of Gas6 action could be glycogen synthase 
kinase-3 (GSK3), which has been shown to mediate contact inhibition by interacting with the 
Wnt pathway (Goruppi et al. 2001). 
Interaction of the Axl kinase domain with the adaptor protein Grb2 (Fridell et al. 
1996; Braunger et al. 1997) seems to be the necessary link with Ras mediated activation of 
the mitogen activated protein kinase (MAPK) pathway of the extracellular regulated kinases 
(ERK). In this context, it is interesting to note that early studies found an Axl dependent 
phosphorylation of the ribosomal protein S6 kinase (RPS6KB1), which activity leads to an 
increase in protein synthesis and cell proliferation (Goruppi et al. 1997). As mentioned 
before, the activation of the Ras/ERK pathway is essential for the observed mitogenic activity 
of Gas6 (Goruppi et al. 1996; Fridell et al. 1996; Stenhoff et al. 2004). A related adapter 
protein containing SH2 binding domains, Nck2, was also found to interact with Axl in the 
two hybrid system (Hafizi et al. 2002). This interaction is interesting, as it could provide a 
link of Axl activation with integrin-linked kinases, affecting in this way the cytoskeletal 
dynamics through focal adhesions and providing a cooperative pathway with integrin 
signaling (Hafizi & Dahlbäck 2006), as has been shown for MerTK (Wu et al. 2005; Nandrot 
& Finnemann 2006; Finnemann & Nandrot 2006). This process is probably mediated by 
interaction with Vav1 and small GTPases of the Rho family (Mahajan & Earp 2003). The 
activation of another phosphatase, SHP-2, has been shown to be essential for the effect of 
Gas6/Axl on inhibition of vascular endothelial growth factor receptor 2 (VEGFR2, FLK1, 
KDR) signaling on endothelial cells (Gallicchio et al. 2005).  
The cross-talk between Gas6/Axl and KDR illustrates the way in which cells integrate 
signals from different stimuli, thereby coordinating and refining complex responses. An 
interesting example of this cooperation has been provided by the study of IL-15 anti-
apoptotic effect. In this case, a direct interaction of the Axl receptor with the receptor for IL-
15 has been demonstrated and shown to be relevant for the signaling cascades of both 
receptors. IL-15 is able to transactivate Axl through its specific receptor IL-15R (Budagian et 
al. 2005b). In an Axl dependent manner, IL-15 is able to activate the Akt/PKB pathway and 
induce survival to TNF-  in Axl transfected cells. Differences among the cells studied 
suggest that specific mechanisms related to putative partners of the Gas6/Axl system could be 
acting in different cell types leading to relevant changes in the response to Gas6. 
Furthermore, these studies demonstrate that differences in the extracellular part of the 
receptors could contribute not only to ligand recognition, but also to partner recruitment. 
Other signaling pathways activated by Gas6/Axl have been studied. Some studies 
found a transient activation of other MAPKs, including JNK/SAPK and p38 (Bellosta et al. 
1997; Goruppi et al. 1999). The later activation has been shown to be important in the 
migration of GnRH neurons (Allen et al. 2002; Nielsen-Preiss et al. 2007). Finally, the Janus 
kinase (JAK) pathway is also affected by Gas6/Axl, leading to activation of signal 
transduction and activators of transcription factors (STATs). As mentioned earlier, the 
mitogenic effect of Gas6 on mesangial cells was shown to be mediated by activation of 
STAT3 through stimulation of Axl (Yanagita et al. 2001b). This effect has been shown to be 
important in the development of certain models of renal disease (Yanagita et al. 2002; 
Yanagita 2004). 
 The signaling pathways initiated by Tyro3 have been comparatively less studied to 
those initiated by Axl or MerTK. Apart from autophosphorylation of the receptors, Tyro3 and 
MerTK have been found to bind and activate Src kinase (Toshima et al. 1995; Wu et al. 
2005), similarly as was observed for Axl (Braunger et al. 1997). The activation of regulatory 
subunits of PI3K has also been demonstrated for Tyro 3 (Lan et al. 2000). In osteoclasts, 
Gas6 has been shown to stimulate Tyro3 through a Ras/ERK mediated mechanism (Katagiri 
et al. 2001). Interestingly, in this cell type no activation of alternative MAPK pathways was 
reported (Katagiri et al. 2001). Constitutively active forms of MerTK have been shown to 
autophosphorylate residues Y749, Y753 and Y754 and, upon activation, phosphorylate PLC-
γ, PI3K, Shc, Grb2, Raf-1, and ERK downstream the receptor (Ling et al. 1996). In a second 
study, the binding to Grb2 was shown to be dependent on Y872, and it is essential in the 
PI3K activation leading to an anti-apoptotic signal through activation of the NF B pathway 
(Georgescu et al. 1999). In contrast to the mitogenic activity observed with Axl activation, 
MerTK kinase domain rescued cells from apoptosis, but did not induce proliferation, despite 
activating ERK, PI3K and p38 pathways (Guttridge et al. 2002). PLC-  has been shown to 
interact and be a substrate of MerTK, is essential in phagocytosis of apoptotic cells (Todt et 
al. 2004). Again, PLC-  has also been shown to bind Axl, where it could be implicated also in 
a pathway affecting the dynamics of the cytoskeleton (Braunger et al. 1997; Nielsen-Preiss et 
al. 2007).  
As was shown for Axl, MerTK has been shown to activate the Jak/STAT pathway 
leading to increased activation of Stat3 and increased transformation efficiency (Besser et al. 
1999). In this context, it is interesting to note that another partner of Axl found by the yeast 
two-hybrid assay was SOCS-1, a negative regulator of cytokine signaling acting through the 
inhibition of Jak phosphorylation, and therefore inhibiting the Jak/STAT pathway (Hafizi & 
Dahlbäck 2006). Although not studied, it is possible that a similar interaction is provided by 
MerTK. From these studies, the general view shows that due to the high conservation in the 
intracellular sequence of the TAM receptors; most interacting partners are common, although 
each receptor in the family show marked differences in the biological function of the three 
receptors. 
 
V. Role of the Gas6/TAM system in vascular biology. 
One of the first discoveries linking Gas6 with the biology of vascular vessels was the 
already mentioned cloning of a growth potentiating factor of VSMCs, shown to be Gas6 
(Nakano et al. 1995). Axl was also cloned from the rat carotid artery after mechanical 
damage. Both Gas6 and Axl increased their expression in this model, meanly in the 
developing neointima up to 14 days after damage, the increase in Gas6 preceding that of the 
receptor (Melaragno et al. 1998; Melaragno et al. 1999). Given the earlier studies showing an 
anti-apoptotic and mitogenic effect of the Gas6/Axl system in cultured cells, it was supposed 
that proliferating cells would need the signaling through Gas6/Axl in order to migrate and/or 
proliferation of VSMCs. The clear effect observed in VSMCs migration in cell culture 
(Fridell et al. 1998) indicates that Gas6 could also play a role in these systems in vivo, 
affecting neointima migration as well as the organization of the atherosclerotic plaque 
(Lutgens et al. 2000). Indeed, Axl deficient mice show a decreased neointima formation after 
mechanical injury (Konishi et al. 2004; Korshunov et al. 2006). Nevertheless, the Axl 
knockouts showed not only a decreased number of proliferating muscular cells, and an 
increase in apoptosis, but also less macrophages and neutrophils (Korshunov et al. 2006). A 
parallel situation has been reported in atherosclerosis of Gas6-/- animals, were a lower 
content of lymphocytes and macrophages has been found (Lutgens et al. 2000).  
Apart from the effect on VSMCs, a role of Gas6 on the endothelium has been 
suggested from its anti-apoptotic effect in culture (O'Donnell et al. 1999; Healy et al. 2001; 
D'Arcangelo et al. 2002; Hasanbasic et al. 2004). In the one hand, the decreased content in 
macrophages and neutrophils in Axl-/- mice during intimal thickening suggests differences in 
cell recruitment, a process mediated by endothelial/leukocyte interactions  (Korshunov et al. 
2006). On the other hand, the addition of Gas6 has been shown to inhibit adhesion of 
granulocytes to endothelial cells (Avanzi et al. 1998). These studies suggest an effect of the 
Gas6/TAM system on endothelial function beyond the anti-apoptotic effect observed in 
cultured endothelial cells. 
Recently, an important function of Gas6 has been described in relation to the 
differentiation of pericytes. Vascular pericytes undergo osteogenic differentiation in vivo 
which may be implicated in diseases involving ectopic calcification and osteogenesis, a 
process that was inhibited by Gas6/Axl signaling (Collett et al. 2003). This effect is not 
completely surprising considering several reports implicating the Gas6/TAM system in 
osteoclast function (Nakamura et al. 1998; Katagiri et al. 2001; Kawaguchi et al. 2004). It has 
recently been reported that the induction of calcification of cultured VSMCs is inhibited by 
Axl (Collett et al. 2007), and the reversion of the process by statins was also mediated by 
activation of the Gas6/Axl pathway (Son et al. 2006; Son et al. 2007). In this context, the 
linkage between genetic variants in GAS6 and stroke could be due to the effect of Gas6 on 
vascular calcification, a process clearly associated with the risk of stroke (Munoz et al. 2004).  
Platelets are key players in the cardiovascular system, not only providing primary 
hemostasis, but also mediating inflammatory responses and cellular interactions. Gas6 is 
found in platelets from rats and mice (Ishimoto & Nakano 2000; Angelillo-Scherrer et al. 
2001), and animals deficient in Gas6 are protected in thrombosis models and their platelets 
are less prone to activation (Angelillo-Scherrer et al. 2001). Both MerTK and Axl and to a 
lesser extent Tyro3, have been proposed as mediators of this function using knockout mice 
and antibody inhibition (Angelillo-Scherrer et al. 2001; Chen et al. 2004; Gould et al. 2005; 
Angelillo-Scherrer et al. 2005). However, further studies showed that the concentration of 
Gas6 in human platelets was lower than the concentration found in plasma, and did not affect 
platelet response (Balogh et al. 2005; Clauser et al. 2006). Still, Gas6 could affect antiplatelet 
drug responsiveness (Burnier et al. 2006). Recently, the extracellular part of MerTK has been 
shown to be able to inhibit platelet aggregation and pulmonary embolism, further 
emphasizing that, at least in mice, the Gas6/TAM pathway is involved in hemostasis (Sather 
et al. 2007). 
 
VI. Gas6 in innate immunity: a modulator of the inflammatory response 
Cells from the immune system express TAM receptors and their ligands. TAMs are 
detected on antigen presenting cells from both peripheral blood or spleen, thymus and lymph 
nodes either with specific antibodies after cell sorting or by in situ hybridization (Neubauer et 
al. 1994; Lu & Lemke 2001; Behrens et al. 2003; Mahajan & Earp 2003; Sen et al. 2007). In 
contrast, TAMs are not expressed in granulocytes or blood lymphocytes (Neubauer et al. 
1994; Graham et al. 1995). It is likely that most monocytic cells express more than one TAM 
receptor, although it cannot be excluded that certain populations express only specific 
receptors (Lu et al. 1999; Lemke & Lu 2003a).  The function of TAM receptors in the 
immune system is dramatically illustrated in animals deficient in all three receptors (Lu et al 
1999, Lu et al 2001). TAM deficient animals survive and do not present defects during early 
life. Peripheral lymphoid organs are normal, indicating a broadly normal hematopoiesis, but 
from one month of age, spleens and lymph nodes grow disproportionately, reaching 10 times 
the weight of these organs in wild type mice. While all three mutations are involved in this 
phenotype, the MerTK mutation produces the largest effect (Lu & Lemke 2001; Scott et al. 
2001). Animals deficient in MerTK present defects in monocyte function, including an 
enhanced sensitivity to endotoxic shock (Camenisch et al. 1999), a delayed clearance of 
apoptotic cells and splenomegaly (Scott et al. 2001; Cohen et al. 2002). TAM or MerTK 
deficient animals show signs of autoimmunity, with features resembling certain human 
autoimmune pathologies including serum autoantibodies against DNA, collagen and 
antiphospholipid antibodies (i.e. anticardiolipin antibodies) and lymphocyte activation and 
hyperproliferation (Lu et al. 1999; Lu & Lemke 2001). The fact that lymphocytes become 
activated in TAM deficient mice, despite not expressing the TAM receptors, indicates that 
autoimmunity in these animals is mediated through a cell-dependent mechanism. Probably 
the lack of an inhibitory signal arising from Gas6/TAM lowers the activation state of antigen-
presenting cells subsequent to an initial immune response. Multiple observations, made in 
both the MerTK single mutants and the triple TAM mutants, are consistent with this 
suggestion. First, macrophages from MerTK mutants and TAM deficient animals, when 
challenged with bacterial lipopolysaccharide (LPS), express unusually high levels of 
activated NFκB, and the mice are hypersensitive to LPS-induced endotoxic shock, tissue 
damage and death as a result of the excessive production of TNF-α (Lu et al. 1999; 
Camenisch et al. 1999; Scott et al. 2001; Cohen et al. 2002; Sen et al. 2007). Markers of 
antigen-presenting cell activation, including cell-surface expression of MHC class II and the 
B7 co-receptors, are constitutively activated in the TAM mice in comparison to wild type 
mice and are consistently hyperactivated in response to LPS challenge (Lu & Lemke 2001).  
In addition to lymphocyte hyper-responsiveness, the second key feature displayed by 
TAM mutants that almost certainly contributes to their development of autoimmune disease 
is that macrophages fail to clear apoptotic cells. This phenomenon has been most thoroughly 
analyzed in the MerTK single mutants (Scott et al. 2001; Cohen et al. 2002; Li et al. 2006; 
Sen et al. 2007). The delayed clearance of apoptotic cells is dependent on the ability of the 
vitamin K-dependent protein S and Gas6 to bind to phosphatidylserine and acidic 
phospholipids through their amino-terminal Gla domains (Nakano et al. 1997a; Scott et al. 
2001; Cohen et al. 2002; Wu et al. 2006; Sen et al. 2007). Probably, the lack of efferocytosis 
is enhanced in the TAM deficient animals by an increased cell death due to the lack of an 
anti-apoptotic rescue signal, as has been shown for Gas6 in cell cultures. In vivo, an increased 
apoptotic cell death has been observed in retina, brain, gonads and other organs, suggesting 
that TAMs play a role in maintaining the cellular homeostasis of organs beyond their function 
in the immune response (Lu et al. 1999; Lu & Lemke 2001; Lemke & Lu 2003b). 
 
VII. Further functions of Gas6/TAM receptors in cellular homeostasis. 
The role of Gas6 on cellular homeostasis, related to its mitogenic and anti-apoptotic 
properties, has been implicated in several organs and models of disease. Considering the 
tissue distribution of both ligands and receptors, it was expected that the Gas6-Protein 
S/TAM system would have implications in neural tissues. Tyro3 single mutants exhibit 
compromised central nervous system (CNS) function (diminished hippocampal long-term 
potentiation [LTP]) as young adults and, when aged, they exhibit neural degeneration 
accompanied by seizures and hind limb paralysis (Lu et al. 1999). This phenotype is clearly 
more severe in the animals deficient in all TAM receptors (Lu et al. 1999). Gas6 has also 
been implicated in the cellular homeostasis of the kidney after certain damages, including 
nephrotoxic nephritis and diabetic glomerulopathies (Yanagita et al. 1999; Yanagita et al. 
2001a; Yanagita et al. 2002; Nagai et al. 2005). The mechanism of action seems to be 
mediated by the mitogenic effect of Gas6 on mesangial cells. Mesangial cell proliferation is a 
general characteristic of a variety of glomerular diseases (Yanagita et al. 1999; Yanagita et al. 
2001a; Yanagita et al. 2001b). A third system where Gas6 function has been implicated is in 
the development of germinal cells (Matsubara et al. 1996). Most TAM deficient animals are 
infertile due to the degeneration of all germ cells in the gonads (Lu et al. 1999). These 
observations support the view that Gas6 could act as a factor maintaining at least certain stem 
cells alive and in their undifferentiated state (Matsubara et al. 1996; Li et al. 1996; Nakamura 
et al. 1998; Dormady et al. 2000; Player et al. 2006). 
 
VIII. Overlapping functions of Gas6 and protein S. 
From very early after the discovery of the Gas6/Axl ligand/receptor interaction 
(Varnum et al. 1995), some researchers discovered an interaction of protein S with receptors 
of the TAM family (Stitt et al. 1995). In this study, it was proposed that human protein S was 
able to interact with Tyro3 in a parallel way to Gas6 interaction with Axl. Nevertheless, it 
was also found that species differences were distinctly important in the affinity of the 
different ligands with the TAM receptors (Godowski et al. 1995; Nagata et al. 1996; Mark et 
al. 1996). Indeed, purified human protein S was not able to bind to the extracellular domains 
of human Tyro3 or the other TAM receptors in the same assays were it was able to bind the 
extracellular domain of mouse Tyro3. Interestingly enough, bovine protein S seems to be able 
to bind and activate both the human and mouse receptors (Godowski et al. 1995; Nyberg et 
al. 1997). Despite this lack of binding activity, human protein S is capable of inducing 
phosphorylation of human Tyro3 in certain cell types at higher concentrations than human 
Gas6 or bovine protein S (around 200 nM), but still lower than the concentration of protein S 
found in plasma (Evenas et al. 2000). In plasma, protein S has a concentration of 350 nM, but 
almost 60% is bound to the complement regulatory factor C4BP (Giri et al. 2002). Binding to 
C4BP abolishes protein S binding to TAM receptors (Nyberg et al. 1997), but C4BP does 
binds Gas6 with a very low affinity (Evenas et al. 1999). One of the problems that makes 
more difficult to evaluate the results published so far is the capacity of purified protein S of 
multimerizing in high molecular weight complexes that have specific properties, different 
from protein S monomers (Heeb et al. 2006). This effect has been studied regarding the 
anticoagulant properties of protein S, but has not been taken into account in relation to their 
putative effects on receptor binding. Furthermore, purified Gas6 preparations show a similar 
behavior, and this could affect the interpretation of the results obtained in purified systems 
(Stenhoff, Hafizi and Dahlbäck, personal communication).  
Despite these discrepancies on the putative effect of protein S on TAM receptors, 
several studies in vivo suggest that protein S, and in particular human protein S, has a 
function as a ligand of TAM receptors. In the one hand, protein S was found to be the serum 
factor responsible of the stimulation of the phagocytosis/efferocytosis (Anderson et al. 2003). 
Protein S-depleted serum or antibodies against protein S could block the effect of serum on 
clearance of apoptotic cells by macrophages. Furthermore, the effect of purified protein S 
was also specific for apoptotic cells, not affecting other forms of phagocytosis. This finding is 
indicative that the Gla-dependent interaction with negatively charged phospholipids 
membranes was necessary for the effect of protein S (Anderson et al. 2003). A second system 
where the effect of protein S as a TAM ligand has been demonstrated is the retina. MerTK-
deficient animals were found to be blind as a result of the complete degeneration of 
photoreceptors during the first month of life (Hall et al. 2001; Collett et al. 2003; Hall et al. 
2005; Prasad et al. 2006; Nandrot & Finnemann 2006; Finnemann & Nandrot 2006). 
Interestingly, a parallel line of research found that the Royal College of Surgeons (RCS) rat, a 
decades-old animal model of retinitis pigmentosa, had a mutated MerTK gene (Nandrot et al. 
2000), and mutations in the human MerTK gene have been detected in patients with retinitis 
pigmentosa (Gal et al. 2000). Several lines of evidence suggest that, at least in mice, the 
protein S/MerTK pair is the most relevant system in the retina, including the presence of 
protein S in the retina, the lack of phenotype in Gas6 deficient animals (Hall et al. 2005; 
Prasad et al. 2006) and the ability of mouse protein S to activate MerTK in extracts of retina 
(Prasad et al. 2006). 
In general, a strong suggestion of a role of protein S as a ligand to TAM receptors 
derives from comparing different knockout models. If Gas6 would be the only and essential 
ligand of all three TAM receptors, one would expect a similar phenotype of TAM deficient 
and Gas6 deficient animals. This is not the case, as Gas6 deficient animals do not have a 
similar spontaneous phenotype to the TAM triple knockouts (Lu et al. 1999; Angelillo-
Scherrer et al. 2001; Yanagita et al. 2002), not showing signs of autoimmune disease, 
infertility or seizures. This clearly indicates the presence of alternative mechanisms of TAM 
receptor activation, and most likely protein S could be a rescue factor of some of these 
phenotypes in Gas6 deficient animals. Other ligands, as IL-15 or soluble or cell-bound Axl 
cannot be excluded (Budagian et al. 2005a; Budagian et al. 2005b).   
 
IX. The implications of vitamin K in Gas6 function. 
In most studies, the presence of a properly carboxylated Gla module in Gas6 has 
been found to be essential for Gas6 function. This was evident from the first report describing 
the interaction of Gas6 with Axl. The authors already noticed that producing Gas6 under 
warfarin-induced inhibition of vitamin K-dependent -carboxylation abolished completely the 
Axl receptor auto-phosphorylation (Varnum et al. 1995). This lack of activity of Gas6 
produced on warfarin was extended to in vitro binding studies, where Gas6 lacking -
carboxylated residues was unable to bind Axl (Tanabe et al. 1997). This suggested that the 
Gla domain could affect the binding site of the receptor, although the LG domains in Gas6 
seemed to contain the binding site for TAM receptors (Mark et al. 1996; Evenas et al. 2000; 
Fisher et al. 2005). Gas6 binds to phosphatidylserine-containing phospholipid membranes in 
an analogous manner to the rest of the proteins of the family, dependent on the Gla module 
and therefore of vitamin K action (Nakano et al. 1997a; Ishimoto et al. 2000; Hasanbasic et 
al. 2005). Warfarin abrogates Gas6-mediated protection of fibroblasts, VSMCs and 
endothelial cells from serum starvation-induced apoptosis (Nakano et al. 1997b; Stenhoff et 
al. 2004; Konishi et al. 2004; Hasanbasic et al. 2005). Proliferation of certain cells could also 
be abolished by warfarin through a Gas6 dependent mechanism, as in neointima formation 
(Konishi et al. 2004) and mesangial cell proliferation (Yanagita et al. 1999; Yanagita et al. 
2001a). Finally, macrophage-mediated clearance of apoptotic cells is also inhibited by 
warfarin effect on Gas6 Gla domain (Hall et al. 2002). 
This cellular effects have been translated to in vivo models, using oral anticoagulation 
to test the effect of inhibition of -carboxylation of Gas6 in different contexts. In the retina 
and other models of efferocytosis, Gas6 needs to be  carboxylated in order to be functional 
(Ishimoto et al. 2000; Hall et al. 2002). Mesangial cell proliferation is also inhibited by 
warfarin through its action on Gas6 (Yanagita et al. 2001a). The concentration of oral 
anticoagulants as warfarin necessary to inhibit Gas6-dependent effects were comparable or 
lower than therapeutic concentrations, indicating that the effects observed in animal models 
could translate to effects in humans (Yanagita et al. 2001a). Interestingly, Gas6 in plasma has 
been shown to be affected by oral anticoagulants (Balogh et al. 2005). The decrease in Gas6 
concentration in anticoagulated patients compared to a control group was similar to that 
observed in protein S (Zöller et al. 1995). Although the concentration of Gas6 in plasma 
could not be as crucial as the local production of the ligand, it could still reflect a systemic 
effect of oral anticoagulants on the Gas6/Axl system. Therefore, it would be interesting to 
evaluate if patients in chronic anticoagulant therapy could present side-effects derived from 
the decrease in Gas6 function. 
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Figure 1. Schematic representation of Gas6, protein S and the three members of the TAM 
receptor family, Tyro3, Axl and MerTK. The domains were predicted with the Simple 
Modular Architecture Research Tool (SMART) program (http://smart.embl.de/) and 
represented using pfam graphical view of domain structure, from the Sanger institute 
(http://www.sanger.ac.uk/). The tyrosine kinase active sites are indicated (  ). 
 
Figure 2. Expression of selected plasma vitamin K-dependent proteins in a subset of human 
(red bars) and mouse (blue bars) organs. Data were obtained from the Symatlas microarray 
expression database and represent the relative value of expression of each gene 
(http://symatlas.gnf.org/; Su et al. 2002). 
 
